For this, Tsai et al. (2017) have developed CRISPR/Cas9-based amplification-free target enrichment method (No-Amp targeted sequencing, Table 2), which was used to capture repeat the expansion locus in Huntingtin (HTT), responsible for Huntington’s disease (Hoijer et al., 2018). This evidence concerns the gene HTT and Huntington disease.